BNC Wealth Management’s AbbVie ABBV Stock Holding History

BNC Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Sell	1,055 -17	-2%	-$3.66K	0.06%	90
2026 Q1	$233K	Sell	1,072 -16	-1%	-$3.55K	0.06%	96
2025 Q4	$249K	Hold	1,088	–	–	0.06%	89
2025 Q3	$252K	Sell	1,088 -2	-0.2%	-$407	0.06%	89
2025 Q2	$202K	Hold	1,090	–	–	0.06%	96
2025 Q1	$228K	Buy	+1,090	New	+$212K	0.08%	86
2024 Q4	–	Sell	-1,101	Closed	-$217K	–	97
2024 Q3	$217K	Buy	+1,101	New	+$205K	0.08%	86
2024 Q2	–	Sell	-1,126	Closed	-$205K	–	100
2024 Q1	$205K	Buy	+1,126	New	+$194K	0.09%	97
2023 Q2	–	Sell	-1,261	Closed	-$201K	–	100
2023 Q1	$201K	Buy	1,261 +5	+0.4%	+$764	0.11%	103
2022 Q4	$203K	Buy	+1,256	New	+$193K	0.12%	100
2020 Q4	–	Sell	-823	Closed	-$72K	–	97
2020 Q3	$72K	Buy	+823	New	+$77.5K	0.05%	139

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNC Wealth Management's ABBV Position: Q2 2026 in Review

BNC Wealth Management reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $3.66K and leaving 1,055 shares worth $265K. The position accounts for 0.06% of the portfolio, ranked #90.

BNC Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 11 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BNC Wealth Management held 1,055 shares of AbbVie worth $265K as of Q2 2026.
BNC Wealth Management sold 17 AbbVie shares in Q2 2026, an estimated $3.66K.
AbbVie made up 0.06% of BNC Wealth Management's portfolio in Q2 2026, its #90 holding.
BNC Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 11 quarters since.
4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BNC Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.